Trending Stocks
Top 10 from Yahoo Finance + StockTwits with daily-bar technical analysis. Cached 5 min. Educational only — not financial advice.
$47.83
-1.07%
Enphase Energy, Inc.
Enphase Energy, SolarEdge Jump 8% as Solar Stocks Ride an AI Data Center Power Theme24/7 Wall St.ENPH, SEDG Stocks Surge After Reported Plan To Ban Chinese Inverters In US – Retail Says It Adds ‘Gasoline To A Fire That Was Already Ripping’StocktwitsEnphase Energy, Solar stocks, rally on report of potential U.S. restrictions on foreign inverter imports (ENPH)InvestorsHub
BUY
Near support $44.45, RSI 44 (oversold)
BUY ZONE
$44.45 – $48.66
SELL ZONE
$68.59 – $72.80
RSI44
TRENDBULLISH
EMA20$51.33
EMA50$46.42
ATR$4.21
$159.99
+15.10%
AeroVironment, Inc.
Stock Market Today: Nasdaq Tests Critical Level; This Drone Maker Rockets Higher On Earnings (Live Coverage)Investor's Business DailyAeroVironment Q4 2026 earnings beat, AVAV stock soarsQuartzAeroVironment Stock Jumps 21% After Strong Earnings ReportBarrons.com
NEUTRAL
Bearish trend, RSI 47, mid-range
BUY ZONE
$135.20 – $146.45
SELL ZONE
$194.30 – $205.55
RSI47
TRENDBEARISH
EMA20$161.71
EMA50$172.60
ATR$11.25
$15.89
-4.28%
Jack In The Box Inc.
Jack in the Box shares extend rally as short squeeze gathers momentum (JACK)InvestorsHubJACK Stock Gains Premarket: Short Squeeze Drives Momentum After Russell Addition, Retail Eyes BreakoutStocktwitsJack in the Box and First Watch Stocks Trade Up, What You Need To KnowStockStory
NEUTRAL
Bullish trend, RSI 65, mid-range
BUY ZONE
$10.92 – $12.25
SELL ZONE
$15.97 – $17.30
RSI65
TRENDBULLISH
EMA20$13.16
EMA50$12.55
ATR$1.33
$493.71
+8.28%
Astera Labs, Inc.
One Thing I’m Watching: The Great Tech DivergenceThe Wall Street JournalUS Stock Market Today: S&P 500 Futures Climb As Rate Jitters Meet Trade WorriesSimply Wall St.Astera Labs (ALAB) Soars to All-Time High — This Propelled the RallyInsider Monkey
SELL
Near resistance $499.48, RSI 73 (overbought)
BUY ZONE
$303.00 – $342.15
SELL ZONE
$460.33 – $499.48
RSI73
TRENDBULLISH
EMA20$385.21
EMA50$299.97
ATR$39.15
$13.95
-9.74%
SELLAS Life Sciences Group, Inc
SELLAS Life Sciences (SLS) Updates Severance Terms As Buyout Talk BuildsSimply Wall St.Sellas Life (SLS) Climbs to Record High on Acquisition BuzzInsider MonkeyWhy Did SLS, BB, OUST Stocks Surge To 52-Week Highs Today?Stocktwits
NEUTRAL
Bullish trend, RSI 74, mid-range
BUY ZONE
$7.07 – $8.24
SELL ZONE
$14.71 – $15.88
RSI74
TRENDBULLISH
EMA20$9.76
EMA50$7.68
ATR$1.17
$6.39
-1.77%
Lucid Group, Inc.
Tesla Jumps 8%, Rivian and Lucid Rise 7% as EV Stocks Ride a Tech Rebound24/7 Wall St.Why Lucid (LCID) Stock Is Up TodayStockStoryTrading Near an All-Time Low of $5: 1 Crucial Balance Sheet Metric That Explains Why Lucid Is a Dangerous Capital-Destruction Trap24/7 Wall St.
WATCH SELL
Approaching resistance $6.81, RSI 61
BUY ZONE
$4.47 – $4.91
SELL ZONE
$6.37 – $6.81
RSI61
TRENDBEARISH
EMA20$5.64
EMA50$6.26
ATR$0.44
$11.20
+8.11%
Candel Therapeutics, Inc.
Candel Therapeutics Announces Initiation of Global Pivotal Phase 3 AURORA Trial Evaluating Aglatimagene Besadenovec (CAN-2409) in Advanced Non-Small Cell Lung Cancer Patients with Inadequate Response to Immune Checkpoint InhibitorsGlobeNewswireCandel Therapeutics Designates Mark Sims as CCOExec EdgeCandel Therapeutics Appoints Mark Sims as Chief Commercial OfficerGlobeNewswire
SELL
Near resistance $11.27, RSI 78 (overbought)
BUY ZONE
$7.93 – $8.54
SELL ZONE
$10.66 – $11.27
RSI78
TRENDBULLISH
EMA20$9.08
EMA50$7.95
ATR$0.61
$17.72
+4.11%
Sarepta Therapeutics, Inc.
Sarepta Therapeutics Gets FDA Review for Duchenne Muscular Dystrophy ApplicationsMT NewswiresSarepta Announces FDA Acceptance of sNDAs for AMONDYS 45® and VYONDYS 53®Business WireSarepta's Elevidys Showing Signs of Stabilization as siRNA Pipeline Gains Importance, RBC SaysMT Newswires
WATCH SELL
Approaching resistance $18.18, RSI 55
BUY ZONE
$14.68 – $15.58
SELL ZONE
$17.28 – $18.18
RSI55
TRENDBEARISH
EMA20$16.86
EMA50$18.35
ATR$0.90
$132.56
+37.87%
Abivax SA
Abivax stock surges on obefazimod safety data, cancer concernsQuartzWall Street Set to Open Marginally Lower in Tuesday Trading; Investors Continue to Monitor Middle East Conflict, Await Key Labor DataMT NewswiresAbivax shares jump 36% as new trial data support ulcerative colitis drug obefazimodEuronews
SELL
Near resistance $134.07, RSI 66 (overbought)
BUY ZONE
$69.81 – $79.31
SELL ZONE
$124.57 – $134.07
RSI66
TRENDBEARISH
EMA20$104.05
EMA50$109.73
ATR$9.50
$42.49
-2.27%
Boston Scientific Corporation
Boston Scientific (BSX) Invests $1.5B in MiRus for Equity Stake and TAVR Acquisition OptionInsider MonkeyEdwards wins FDA clearance for LAA clip, setting up competition with AtriCure and MedtronicMedTech Dive3 Value Stocks to Research FurtherStockStory
BUY
Near support $42.46, RSI 25 (oversold)
BUY ZONE
$42.46 – $43.88
SELL ZONE
$48.72 – $50.14
RSI25
TRENDBEARISH
EMA20$46.47
EMA50$51.99
ATR$1.42